On completion of this activity, which contains 9 articles on important new data presented at the 2026 Conference on Retroviruses and Opportunistic Infections, the learner will be better able to: Summarize available evidence on islatravir susceptibility and incorporate this information into clinical decision-making, particularly in the presence of previously selected or transmitted resistance mutations Describe an integrated approach combining behavioral, pharmacologic, and procedural strategies to manage weight gain and obesity in people with HIV Describe the latest findings on clinical pharmacology presented at the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs List foundational strategies to mitigate frailty and sarcopenia in people with HIV Describe a conceptual framework for understanding neurodivergence in the context of HIV, summarize available epidemiologic and outcomes data, and incorporate practical strategies for delivering neurodiversity-affirming, accessible care
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
CME included with membership
| On-Demand CME Course Fee | $55 |
Collected from the provider’s public pages · source
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Recorded-from-live session
- Credit · Up to 4.5 credits
- Commercial Support
-
ReleasedJul 16, 2026
-
Last day to claim creditJul 17, 2027 9 months left
-
AAHIVM +1 2026 HIV and Aging: Drug-drug Interactions and Polypharmacy in Older Adults with HIV
-
Clinical Care Options, LLC (dba Decera Clinical Education) A Switch in Time: State-of-the-Art Strategies for ART Modification in Virologically Suppressed People Living With HIV
-
PVI, PeerView Institute for Medical Education HIV Treatment Advances and Emerging Data: An Update From CROI 2026
-
International Antiviral Society-USA (IAS-USA) TAM March/April 2026 Volume 34, Issue 2
-
International Antiviral Society-USA (IAS-USA) No Mo’ FOMO 2026: In Case You Missed It Recent Changes in Guidelines, New Publications, and Updates From Recent Conferences (On-Demand)
-
International Antiviral Society-USA (IAS-USA) Drug-Drug Interactions, Dosing, Formulations, and Other Pharmacologic Issues in HIV Treatment (On-Demand)
